Correction (DOI:10.1016/j.ahj.2008.12.005);Aborted myocardial infarction: Is it real in the troponin era?

American Heart Journal

Volumn 157, Issue 4, 2009, Pages 636-641

  Vasile, Vlad C ^a   Babuin, Luciano ^a   Ting, Henry H ^a   Bell, Malcolm R ^a   Orme, Nicholas M ^a   Yuan, Brandon Y ^a   Perez, Jose A Rio ^a   Alegria, Jorge R ^a   Bellolio, Fernanda ^a   Haro, Luis H ^a   Jaffe, Allan S ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; TROPONIN; TROPONIN T;

ADULT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REPERFUSION; REVIEW; SEX DIFFERENCE; ST SEGMENT ELEVATION;

EID: 62949102688     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.06.001     Document Type: Erratum

References (19)

1. Antman E.M., Cooper H.A., Gibson C.M., et al. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J 23 (2002) 928-933
2. McNamara R.L., Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006) 2180-2186
3. Reimer K.A., Lowe J.E., Rasmussen M.M., et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977) 786-794
4. Boersma E., Maas A.C., Deckers J.W., et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
5. Taher T., Fu Y., Wagner G.S., et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol 44 (2004) 38-43
6. Lamfers EJ, Hooghoudt TE, Uppelschoten A, et al. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol 1999;84(8):928-30, A6-7.
7. Weaver W.D., Cerqueira M., Hallstrom A.P., et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 270 (1993) 1211-1216
8. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
9. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
10. Verheugt F.W., Gersh B.J., and Armstrong P.W. Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J 27 (2006) 901-904
11. Ting H.H., Rihal C.S., Gersh B.J., et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation 116 (2007) 729-736
12. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144 (2002) 981-986
13. Gersh B.J., Stone G.W., White H.D., et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?. JAMA 293 (2005) 979-986
14. Nallamothu B.K., Bates E.R., Herrin J., et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 111 (2005) 761-767
15. Venge P., Johnston N., Lagerqvist B., et al. Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. Clin Chem 49 6 Pt 1 (2003) 880-886
16. Ottani F., Galvani M., Nicolini F.A., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 140 (2000) 917-927
17. Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343 (2000) 1139-1147
18. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
19. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 335 (1996) 1333-1341